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 Abstract
Introduction: Suspected preterm labour occurs in around 9% of pregnancies. 
However, almost two-thirds of women admitted for threatened preterm labour ultimately 
deliver at term and are considered risk-free for fetal development.  
Methods: We examined placental and umbilical cord blood samples from preterm or 
term deliveries after threatened preterm labour as well as term deliveries without 
threatened preterm labour. We quantitatively analysed the mRNA expression of 
inflammatory markers (IL6, IFNγ, and TNFα) and modulators of angiogenesis (FGF2, 
PGF, VEGFA, VEGFB, and VEGFR1). 
Results: A total of 132 deliveries were analysed. Placental samples from preterm and 
term deliveries after suspected preterm labour exhibited significantly increased 
expression of TNFα and IL6 and decreased expression of IFNγ. Suspected preterm 
labour was also associated with altered expression of angiogenic factors, although not 
all differences reached statistical significance. 
Discussion: We found gene expression patterns indicative of inflammation in human 
placentas after suspected preterm labour regardless of whether the deliveries occurred 
preterm or at term. Similarly, a trend towards altered expression of angiogeneic factors 
was not limited to preterm birth. These findings suggest that the biological mechanisms 
underlying threatened preterm labour affect pregnancies independently of gestational 
age at birth.  
 Keywords
Suspected preterm labour, angiogenesis, sterile inflammation, fetal development, 
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Highlights 
 False preterm labour is considered to pose no risks to fetal development.
 Suspected preterm labour induces inflammatory gene expression in human
placentas.
 Suspected preterm labour alters angiogenic gene expression in human
placentas.
 Biological mechanisms of suspected preterm labour affect term-born
pregnancies.
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 Introduction 
Suspected preterm labour occurs in approximately 9% of all pregnancies.1 However, 
almost two-thirds of women admitted for suspected preterm labour do not deliver 
prematurely. 2  Women who deliver at term after suspected preterm labour are 
considered to have had an episode of "false preterm labour" that poses no risks to 
normal fetal development. 3  However, previous reports suggest that at-term infants 
whose mothers experienced an episode of suspected preterm labour could be at 
increased risk for fetal growth restriction.4,5,6,7,8  Randomized clinical trials assessing the 
effect of tocolysis suggest that after suspected preterm labour, early childhood 
cognitive outcomes are similar between at-term and late-preterm infants.9 In line with 
these results, we recently reported an increased risk of suboptimal neurodevelopment 
in term-born 2-year-old children after an episode of suspected preterm labour.10 Hence, 
in some cases, symptoms of threatened preterm labour may result from a pathological 
insult whose nature or severity is not sufficient to induce irreversible spontaneous 
preterm delivery but that could alter the normal course of pregnancy because the fetus 
is subjected to an adverse intrauterine environment until delivery.4,11
Preterm birth is the final common result of a variety of aetiologies with very different 
biological mechanisms,12 some of which are related to poor neonatal outcomes.13,14 
Previous efforts to prevent preterm birth have been hampered by a poor understanding 
of the underlying pathophysiology, inadequate diagnostic tools, and generally 
ineffective therapies.
13
 Nevertheless, clinical, epidemiological, and experimental
studies indicate that acute and chronic inflammatory conditions in the placenta play a 
critical role in the pathogenesis of preterm birth.15,16  Failed invasion by extravillous 
trophoblast cells leads to placental dysfunction, which results in adverse obstetric 
outcomes including pre-eclampsia, fetal growth restriction, and spontaneous preterm 
delivery. Various endothelial cell-derived angiogenic and antiangiogenic factors are 
important for the invasion process to proceed normally. These include vascular 
endothelial growth factor (VEGF), its receptor fms-like tyrosine kinase-1 (FLT1), soluble 
FLT1 (sFLT1), placental growth factor (PGF), and fibroblast growth factor 2 (FGF2).17 
To determine how inflammatory and angiogenic pathways are affected by suspected 
preterm labour, we examined the expression patterns of genes with known 
inflammatory and angiogenic functions in samples of umbilical cord blood and placenta 
from preterm and term deliveries after suspected preterm labour.  
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 Methods 
Study population 
We conducted a prospective cohort study of preterm (26–36 weeks) or term (≥37 
weeks) delivery pregnancies after suspected preterm labour between September 2011 
and May 2013 at the Hospital Clínico Universitario of Zaragoza, a tertiary university 
center. Suspected preterm labour was defined as the presence of regular and painful 
uterine contractions registered by cardiotocography and ultrasound cervical length <25 
mm in the presence of intact membranes at gestational age of 24+0 to 36+6 weeks.18 
These groups were compared with a group of term delivery singleton pregnancies (≥37 
weeks) without suspected preterm labour that were randomly sampled from our 
general obstetric population during the same time period. Last menstrual period was 
dated according to first-trimester crown-rump length. 19  Pregnancies involving 
congenital malformations, chromosomopathies, infections, and multiple gestations 
were excluded. The local ethics committee approved the study protocol (CEICA 
14/2010), and parents provided written informed consent. 
All pregnancies were managed by a staff obstetrician. Tocolysis with atosiban 
(Tractocile, Ferring Pharmaceuticals, Madrid, Spain), intramuscular betamethasone 
(2×12 mg/24 h), and magnesium sulphate was administered in some cases according 
to international clinical standards. 20  Maternal sociodemographic characteristics and 
clinical data were recorded in the hospital database at study inclusion. Based on the 
results of previous studies,21 the number of subjects required for detecting a >10% 
increase in markers of trophoblast inflammation assuming an alpha error of 5% and 
beta error of 20% was 110.  
Placental and umbilical cord blood samples 
Samples of the placenta and umbilical cord blood were collected immediately after 
delivery. We identified sites at the placental periphery of four lobules that were free of 
visible infarction, calcification, haematoma or damage, and four tissue samples (1–2 
mm) were randomly removed from the maternal surface (basal plate). Tissue samples 
were submerged in RNA Stabilization Solution (RNAlater®, Fisher Scientific®), kept at 
4ºC, and stored at -80°C as suggested by the manufacturer.  
Tissue homogenisation, RNA extraction, and mRNA expression analysis 
Tissue stored at -80ºC in RNAlater® was thawed on ice. Small pieces (200–400 mg) 
were cut from each specimen using dissection scissors and mixed on ice with 1 ml ice-
cold TRIzol™, and then 1.0-mm Zirconia beads (Biospec Products) were added. 
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Tissue was disrupted on a Mini Beadbeater (Biospec Products) for 4 min at room 
temperature. Cell debris and other particulate matter was removed by centrifugation 
(3000g) at 4°C. The resulting homogenate was frozen at -80ºC until further use. RNA 
was subsequently extracted using an in-house method22 based on standard TRIzol™ 
purification protocols (TRIzol®, Thermo Fischer Scientific) adapted from original 
protocols based on guanidinium thiocyanate.23 After DNase I treatment as previously 
described,22 RNA was resuspended, its concentration was measured using Nanodrop, 
and RNA was frozen at -80ºC until further use.  
Reverse transcription (RT) and quantitative polymerase chain reaction (qPCR) 
Total RNA was obtained from 104 high-quality samples, as clinical circumstances 
precluded taking samples from 11 patients, and 18 other samples were excluded due 
to inconsistencies in clinical records (n=8) or inappropriate storage (n=10). Only 
samples with RIN values >3.3 were included in the study, although restricting the 
analysis to samples with RIN values >6.0 did not change the outcome (data not shown). 
RNAs were retrotranscribed using the High-Capacity RNA-to-cDNA™ Kit (4387406, 
Applied Biosystems) at 20 ng RNA/µl reaction. Subsequent qPCR reactions were 
carried out using TaqMan® Gene Expression Master Mix (4370074, Applied 
Biosystems) with 5 ng cDNA per reaction, oligos at 900 nM, and TaqMan probes at 
250 nM in 10 µl reactions. All reactions were carried out in triplicate on a AB7900 HT 
apparatus (Applied Biosystems) using the following cycling protocol: 2 min at 50ºC, 10 
min at 95ºC and 40 cycles of 15 s at 95ºC and 1 min at 60ºC. RT and qPCR assays 
were carried out by a commercial provider (Parque Científico de Madrid; www.fpcm.es). 
TaqMan® assays (Life Technologies) used to analyse the mRNA expression of 
inflammatory markers (interleukin 6 (IL6), interferon gamma (IFNγ, and tumour 
necrosis factor alpha (TNFα) and modulators of angiogenesis (FGF2, PGF, VEGFA, 
VEGFB, and VEGFR1). Data were normalised using GeNorm (URL); no significant 
differences were observed using either 18S rRNA or GAPDH as a reference gene. 
Expression suite (ThermoFisher Scientific) was used to calculate Ct values. Data 
were further recalculated as Ct with respect to the mean/median Ct value of control 
samples.  
Protein markers in serum 
Umbilical artery cord blood samples were obtained in 10-ml anti-coagulation tubes 
(EDTA/citrate), coagulated at room temperature, and centrifuged for 15 min at 1000g. 
After removal of 14 samples due to insufficient quality, we analysed 118 cord blood 
samples. Serum aliquots were stored at -80°C. We used the Magnetic Luminex 
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screening assay from R&D Systems to analyse protein levels for inflammatory markers 
and modulators of angiogenesis (RYD-LXSAHM-06). Duplicate assays were performed 
on 25 μl of plasma according to the manufacturer’s recommendations. Fluorescence 
measures were acquired using the Luminex200 platform (Luminex Corporation). A 
standard curve was generated by serially diluting reconstituted standards. Data were 
collected and analysed with Luminex xPONENT 3.1 software (Luminex Corporation). A 
five-parameter regression formula was used to calculate sample concentration (i.e., the 
mean value of the measurements) from the standard curve. 
Statistical analysis 
Normal distributions were assessed using Kolmogorov-Smirnov tests. Chi-square tests 
and analysis of variance (ANOVA) or Kruskal Wallis tests were used to analyse 
categorical and continuous variables, respectively. Spearman correlation coefficients 
(ρ) were calculated, and p-values were based on the t distribution. Data are presented 
as mean ± standard deviation (SD), median (interquartile range), or number of subjects 
(%). Two-sided p-values <0.05 were considered statistically significant. Statistical 
analyses were performed using SPSS software (v. 20, SPSS Inc., Chicago, IL, USA). 
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 Results
A total of 140 pregnant women who satisfied the inclusion criteria were invited to 
participate in this study. As eight women declined, clinical samples were obtained from 
132 women. Of these, 80 were admitted for threatened preterm labour. Preterm 
delivery occurred in 52 women (65%), whereas the other 28 women delivered at term 
(35%). A randomly selected group of 52 women who delivered at term without previous 
hospital admission were also included. 
Maternal sociodemographic characteristics and perinatal data are shown in Table 1. 
There were no significant differences among groups in the sex of the infants or 
maternal age. More than two-thirds of preterm infants were delivered late preterm. 
Preterm infants had significantly lower birth weights and earlier gestational ages at 
delivery and were significantly more likely to be admitted to the neonatal care unit than 
term-born infants. Placental weights were significantly lower in the suspected preterm 
labour groups than in the term delivery control group. It is important to note that women 
in both suspected preterm labour groups had significantly greater rates of preterm birth 
in previous pregnancies.  
We analysed protein levels of inflammatory markers and modulators of angiogenesis in 
umbilical cord blood samples from 118 women using composite chemiluminescence 
assays. Median values are shown in Table 2. No significant differences among groups 
were observed for IFNγ, VEGF, FGF2, or IL6. Preterm delivery and term delivery after 
suspected preterm labour groups showed similar increases in TNFα expression 
compared with the term delivery control group. PGF expression was also increased 
after suspected preterm labour, with the percentage of subjects with PGF levels >1.5 
multiples of the median (MoMs) in the term delivery control, term delivery after 
suspected preterm labour, and preterm delivery groups being 12.2, 27.3, and 42.2% 
(p=0.004), respectively. There were significant positive correlations between the 
presence of suspected preterm labour and levels of TNFα (0.265, p=0.004) and PGF 
(0.375, p=0.001).  
We also analysed mRNA expression of inflammatory markers and modulators of 
angiogenesis in 104 high-quality placental samples using RT and qPCR. Figure 1 
shows values calculated for each gene for the suspected preterm labour groups 
relative to the term delivery control group. After suspected preterm labour, both the 
preterm delivery and term delivery groups showed increased expression of TNFα, IL6, 
and PGF and decreased expression of IFNγ and VEGFR1. However, only the term 
delivery after suspected preterm labour group showed markedly decreased VEGFA 
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expression, whereas only the preterm delivery group showed a slight decrease in 
VEGFB expression. FGF2 expression was similar across the three groups. 
Statistical analysis showed significant differences among the three groups in VEGFB, 
TNFα, and IL6 mRNA expression in placental samples (Supplementary Table 1). To 
further investigate differences between groups, we performed pairwise comparisons 
(Figure 2). IL6 and TNFα mRNA expression were similarly increased in preterm 
delivery and term delivery after suspected preterm labour groups compared with the 
term delivery control group. However, the expression of VEGFB and VEGFR1 tended 
to be lower in the preterm delivery and term delivery after threatened preterm labour 
groups compared with the control group. A non-significant increase in PGF expression 
was also found in both threatened preterm labour groups.   
Inflammation has previously been identified as a risk factor for preterm delivery.
12,13,14
Therefore, we compared subjects with and without placental inflammation using the 
presence of both IL6 and TNFα mRNA expression >1.5 MoMs as a strict cut-off. 
Inflammation was present at similar frequencies in the preterm delivery and term 
delivery after suspected preterm labour groups (14.6% vs. 13.6%; p=0.946). However, 
the presence of inflammation was significantly more frequent in both suspected 
preterm labour groups compared with the term delivery control group (14.2% vs. 2.4%; 
p=0.045), (Figure 3a) with a positive likelihood ratio of 1.57 (95% confidence interval, 
1.20–2.05). We also found that the presence of suspected preterm labour correlated 
with increased IL6 (0.287; p=0.003) and TNFα(0.216; p=0.028) expression and 
decreased VEGFB expression (-0.244; p=0.013), and the presence of inflammation 
was correlated with increased FGF2 expression (0.377; p=0.002).  
Re-evaluation of mRNA expression levels of angiogenic factors in placental samples 
indicated that inflammation was associated with significantly increased FGF2 
expression (Figure 3). Therefore, we separated subjects with and without inflammation 
within both suspected preterm labour groups (Supplementary Table 2).  
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Discussion 
Our results suggest that similar biological mechanisms affect pregnancies after 
suspected preterm labour regardless of the final gestational age at birth. Specifically, 
we found the presence of gene expression patterns indicative of inflammation in 
human placentas delivered preterm and at term after suspected preterm labour. 
Intra-amniotic inflammation/infection is the only mechanism with persuasive evidence 
of causality for spontaneous preterm delivery.24 Our results are consistent with those of 
previous studies linking increased levels of pro-inflammatory cytokines, placental 
pathology, and preterm delivery.
11,12,13
 Kim et al,25 found the presence of intraamniotic
inflammation in the 12.1% of patients with an increased frequency of premature 
contractions without cervical changes. These results are in line with our study, as we 
report placental inflammation in 14.6% of the preterm delivery and 13.6% of the term 
delivery after suspected preterm labour patients. To avoid potential bias related to 
intra-amniotic inflammation, we excluded patients with preterm rupture of membranes 
at admission or who presented with clinical chorioamnionitis. Thus, we suggest that 
subclinical or sterile inflammation may be a contributing factor to preterm labour. We 
also found positive correlations between suspected preterm labour and both IL6 and 
TNFα gene expression, whereas previous studies of cytokine levels associated with 
preterm labour have largely examined single proteins independently. Our finding is 
compatible with that of a previous study showing that women with preterm labour and 
sterile intra-amniotic inflammation have more coordinated amniotic fluid inflammatory-
related proteins than those without intra-amniotic inflammation.26  
Reduced levels of VEGFA and PGF mRNA were previously observed in placentas 
from late preterm deliveries.27 We found decreased levels of placental VEGFB mRNA 
not only in the preterm delivery group but also in the term delivery after suspected 
preterm labour group, which was consistent with a trend toward decreased expression 
of VEGFA and VEGFR1. Whether the role of the VEGF pathway in threatened preterm 
labour is related to angiogenesis28 or an indirect reduction in circulating progesterone 
levels and subsequent onset of labour and parturition29 is an unresolved question at 
present. 
It has been hypothesized that the symptoms of threatened preterm labour result from a 
pathological insult whose nature and/or severity is not sufficient to induce irreversible 
spontaneous preterm birth but is sufficient to disturb pregnancy11. A growing body of 
evidence suggests that term-born fetuses after threatened preterm labour have an 
increased risk of low birthweight4,5,6,7,8  and adverse perinatal outcomes, such as higher 
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rates of instrumental deliveries, non-reassuring fetal heart rate tracings, prolonged third 
stage of labour, and increased rate of post-partum maternal anaemia.30 We recently 
found that children born at term after threatened preterm labour have an increased risk 
of suboptimal neurodevelopment at 2 years of age10, which is in line with other 
reports11. Intrauterine inflammation to a level insufficient to cause parturition may be 
sufficient to induce fetal injury, even without a maternal immune response.31 Here, we 
observed gene expression patterns indicative of inflammation in human placentas after 
suspected preterm labour regardless of whether the deliveries occurred preterm or at 
term. To the best of our knowledge, this is the first reported evidence of a similarity 
between these two groups. So far, concerns regarding suspected preterm labour have 
focused on preventing preterm birth, but suspected preterm labour itself might be a risk 
factor for prenatal and postnatal adverse outcomes, suggesting the need for more 
surveillance.  
The main strength of our study is that no previous studies have examined the effect of 
suspected preterm labour on placental inflammation and angiogenic pathways. 
However, our study also has some limitations. First, our study design did not allow us 
to examine whether the treatment applied during a suspected preterm labour episode 
could influence placental gene expression. Experimental and observational studies in 
necropsies on preterm babies showed that glucocorticosteroids induce apoptosis in the 
hippocampal neurons in animals as well as human fetuses.32,33 Second, alterations in 
angiogenesis-related gene expression were found in both groups after suspected 
preterm labour, although many of these differences did not reach statistical significance. 
We plan to strengthen our conclusions in the future through a study with larger cohorts 
and determination of protein levels and enzyme activity. In addition, determining 
protein levels, enzymatic activities, and their localisation may enhance our 
understanding of the molecular processes underlying suspected preterm labour. 
We found gene expression patterns indicative of inflammation in human placentas after 
suspected preterm labour regardless of whether delivery occurred preterm or at term. 
Alterations in angiogenesis-related gene expression were also found after suspected 
preterm labour, although not all differences reached statistical significance. These 
results suggest that similar biological mechanisms affect both preterm and term-born 
infants after suspected preterm labour. Further studies are needed to understand the 
possible implications of these findings for fetal development. 
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 Figure legends 
Figure 1. mRNA expression of inflammatory markers and modulators of angiogenesis 
in placental samples from preterm and term deliveries after threatened preterm labour 
relative to term control deliveries. Data are shown as mean±SD.  
Figure 2. mRNA expression of inflammatory markers and modulators of angiogenesis 
in placental samples. Data are shown as median (interquartile range). Data were 
analysed using Kruskal Wallis tests. TDSPL: term delivery after suspected preterm 
labour. 
Figure 3. (a) Percentage of cases with inflammation (both threatened preterm labour 
groups combined). Inflammation was defined by both IL6 and TNF mRNA expression 
>1.5 MoMs. (b-f). mRNA expression of inflammatory markers and modulators of 
angiogenesis in placental samples depending on the state of inflammation. Data are 
shown as median (interquartile range). 
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Table 1. Maternal sociodemographic characteristics and perinatal data. 
Preterm 
delivery 
(n=52) 
Term delivery 
after suspected 
preterm labour 
(n=28) 
Term delivery 
control 
(n=52) 
p 
Maternal age, mean (SD) 29.7 (5.8) 30.2 (6.2) 31.1 (5.7) 0.523 
Maternal body mass index, kg/m
2
,
mean (SD) 
23.4 (3.4) 21.7 (2.8) 25.1 (3.9) 0.001 
Gravity, median (interquartile 
range) 
1 (3) 1 (3) 0 (6) 0.649 
Parity, median (interquartile 
range) 
0 (3) 0 (2) 0 (1) 0.073 
Caucasian, n (%) 42 (80.8) 27 (96.4) 45 (86.5) 0.420 
Smokers, n (%) 5 (9.6) 2 (7.1) 8 (15.4) 0.562 
Preeclampsia, n (%) 1 (1.9) 2 (7.1) 0 (0.0) 0.124 
Gestational diabetes, n (%) 1 (1.9) 2 (7.1) 3 (5.8) 0.487 
Infant sex, male, n (%) 23 (44.2) 20 (71.4) 26 (50.0) 0.062 
Gestational age at birth, days, 
mean (SD) 
243 (16.2) 272 (9.1) 278 (7.1) 0.001 
Previous preterm delivery, n (%) 9 (17.3) 5 (17.9) 1 (1.9) 0.023 
Birth weight, g, mean (SD) 2300 (522.2) 3152 (351.9) 3247 (347.0) 0.001 
Placental weight, g, mean (SD) 456.63 (149.9) 536.63 (130.9) 606.15 (90.2) 0.001 
Cesarean section, n (%) 5 (9.6) 6 (21.4) 12 (23.1) 0.160 
Labour, n (%) 50 (96.2) 23 (82.1) 42 (80.8) 0.044 
Cervical ripening*, n (%) 0 (0.0) 7 (25.0) 11 (21.2) 0.001 
Epidural anesthesia, n (%) 40 (76.9) 25 (89.3) 48 (94.1) 0.035 
Antibiotics in labour**, n (%) 17 (32.7) 7 (25.0) 8 (15.4) 0.118 
Tocolysis***, n (%) 46 (88.4) 24 (85.7) 0 (0.0) 0.009 
Antenatal steroids, n (%) 21 (40.4) 28 (100) 0 (0.0) 0.001 
Maternal oxygen at delivery, n 
(%) 
0 (0.0) 0 (0.0) 0 (0.0) 1 
Magnesium sulphate, n (%) 6 (11.5) 0 (0.0) 0 (0.0) 0.008 
Apgar at 5 minutes 7, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 1 
Neonatal care unit admission, n 
(%) 
30 (56) 3 (11.1) 4 (8.3) 0.001 
Umbilical artery pH 7.10, n (%) 0 (0.0) 0 (0.0) 3 (5.8) 0.207 
*prostaglandin E2; **ampicilin; ***atosiban. Data were analysed using ANOVA (continuous
variables) or Chi-square tests (categorical variables). 
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Table 2. Protein concentrations (pg/ml) of inflammatory markers and modulators of 
angiogenesis in umbilical artery cord blood samples.  
Preterm delivery 
(n=47) 
Term delivery after 
suspected preterm labour 
(n=22) 
Term delivery 
control 
(n=49) 
p 
PGF 1.29 (1.59) 0.8 (1.01) 0.64 (0.74) 0.001 
TNFα 3.63 (2.59) 3.63 (3.76) 2.78 (2.02) 0.011 
IL6 3.70 (13.48) 2.05 (5.78) 1.82 (4.13) 0.107 
FGF2 5.70 (68.35) 0.00 (36.47) 0.00 (41.28) 0.188 
IFNγ 0.18 (0.37) 0.14 (0.30) 0.18 (0.19) 0.546 
VEGF 48.65 (82.93) 48.65 (140.55) 42.30 (156.23) 0.746 
FGF2: fibroblast growth factor 2, IFNγ: interferon gamma, PGF: placental growth factor, TNFα: 
tumour necrosis factor alpha, IL6: interleukin 6, VEGF: vascular endothelial growth factor. Data 
are shown as median (interquartile range). Data were analysed using Kruskal Wallis tests. 
3 
Supplementary Table 1. mRNA expression of inflammatory markers and modulators 
of angiogenesis in placental samples.  
Preterm 
delivery 
(n=41) 
Term delivery after 
threatened preterm labour 
(n=22) 
Term 
delivery 
control 
(n=41) 
p 
VEGFB 0.85 (0.26) 0.97 (0.23) 1.03 (0.36) 0.002 
IL6 1.28 (0.74) 1.24 (0.74) 0.93 (0.76) 0.014 
TNF 1.20 (0.88) 1.39 (0.97) 0.97 (0.82) 0.048 
PGF 1.42 (0.96) 1.37 (0.95) 1.19 (0.75) 0.343 
FGF2 1.02 (0.48) 1.18 (1.72) 1.07 (0.55) 0.342 
VEGFA 0.87 (0.97) 0.78 (0.51) 0.91 (0.70) 0.370 
VEGFR1 0.78 (0.70) 0.81 (0.79) 1.03 (0.79) 0.581 
INF 0.59 (1.76) 0.85 (1.67) 0.72 (2.17) 0.763 
Data are shown as median (interquartile range). Data were analysed using Kruskal Wallis tests. 
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 Supplementary Table 2. mRNA expression of modulators of angiogenesis in 
placental samples depending on the state of inflammation. 
Preterm delivery Term delivery after suspected 
preterm labour 
Inflammation 
(n=6) 
No 
inflammation 
(n=35) 
p 
Inflammation 
(n=3) 
No 
inflammation 
(n=19) 
p 
PGF 0.76 (1.41) 1.45 (0.96) 0.110 1.51 (1.32) 1.37 (0.93) 0.651 
FGF2 1.85 (1.48) 0.99 (0.40) 0.018 1.07 (0.55) 1.14 (0.40) 0.087 
VEGFA 1.71 (3.42) 0.87 (0.54) 0.171 1.11 (0.66) 0.75 (0.47) 0.718 
VEGFB 0.79 (0.44) 0.85 (0.26) 0.438 1.18 (0.10) 0.96 (0.19) 0.408 
VEGFR1 0.61 (0.96) 0.80 (0.76) 0.376 0.71 (0.39) 0.85 (2.07) 0.523 
Inflammation was defined by the presence of placental IL6 and TNFα mRNA expression >1.5 
MoMs. Data are shown as median (interquartile range). Data were analysed using Kruskal 
Wallis tests. 
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